Commit Biologics ApS
Core data
Name | Commit Biologics ApS |
Address | Universitetsbyen 81, 8000, Aarhus C |
Founded | Sep 1, 2021 |
| 24 / 23 | |
Locations (P-units) | 2View locations |
Website | https://commitbio.com/ |
 LinkedIn | commit-biologics |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Name | Commit Biologics ApS |
Address | Universitetsbyen 81, 8000, Aarhus C |
Founded | Sep 1, 2021 |
| 24 / 23 |
Locations (P-units) | 2View locations |
Website | https://commitbio.com/ |
| LinkedIn | commit-biologics |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Keep track of Commit Biologics ApS
Description
Commit Biologics is a biotech spin-out from Aarhus University, founded in 2021. Its team combines expertise in antibody development and complement research to develop therapeutics for cancer and autoimmune diseases.
Develops antibody-based therapeutics using its Bispecific Complement Engaging (BiCE™) platform, designed to activate and direct the complement system to selectively kill tumor cells or cells implicated in autoimmune disease.
Company's own description on virk.dk
Description of key activities of the companyThe company's object is manufacture of pharmaceutical preparations, research and experimental development within biotechnology.
Products & services
Bispecific Complement Engaging (BiCE™) platform · Complement Engager therapeutics
Industries
Biotechnology · Drug development · Immuno-oncology · Autoimmune disease therapeutics
Financials
| Reporting period | 2025DKK | ||||
|---|---|---|---|---|---|
| Gross profit | -23,365,247 | ||||
| Operating profit | -39,469,333 | ||||
| Profit before tax | -39,281,079 | ||||
| Net income | -33,781,079 | ||||
| Total assets | 38,807,917 | ||||
| Equity | 37,898,027 | ||||
| Avg. employees | 17 | ||||
2022–2025 Unlock financial history | |||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Contact
From commitbio.com
| Contact | Phone | |
|---|---|---|
| Main | — | in**@commitbio.comShow full |
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
| Person | Roles | Titles |
|---|---|---|
| Anker Gunvald Lundemose | Roles Board | TitlesFORMAND |
| Nick Stub Laursen | Roles Board | TitlesBESTYRELSESMEDLEM |
| Pieter Jeroen Bakker | Roles Board | TitlesBESTYRELSESMEDLEM |
| Thomas Lars Andresen | Roles BoardManagement | TitlesBESTYRELSESMEDLEM • ADM. DIR. |
| Lars Green | Roles Reelle ejere | TitlesReel ejer |
| Lars Henrik Munch | Roles Reelle ejere | TitlesReel ejer |
| Lars Rebien Sørensen | Roles Reelle ejere | TitlesReel ejer |
| Mads Boritz Grøn | Roles Reelle ejere | TitlesReel ejer |
| Nana Sejbæk | Roles Reelle ejere | TitlesReel ejer |
| Ole Jakob Müller | Roles Reelle ejere | TitlesReel ejer |
| Steen Riisgaard | Roles Reelle ejere | TitlesReel ejer |
| Stig Strøbæk | Roles Reelle ejere | TitlesReel ejer |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| Kovsted & Skovgård, Statsautoriseret revisionspartnerselskab | AuditorDaniel Stampe Grønkjær | RoleStatsautoriseret revisor | FromApr 15, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
Unknown Other Participant | Ownership25–33.32 % | Voting rights25 % | FromJan 8, 2026 |
| Ownership25–33.32 % | Voting rights25 % | FromJan 8, 2026 | |
| Ownership15–19.99 % | Voting rights15 % | FromJan 8, 2026 | |
Unknown Other Participant | Ownership15–19.99 % | Voting rights15 % | FromJan 8, 2026 |
Beneficial owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
Unknown Other Participant | Ownership29.81 % | Voting rights29.81 % | FromApr 1, 2025 |
Unknown Other Participant | Ownership29.81 % | Voting rights29.81 % | FromJan 19, 2024 |
| Ownership29.81 % | Voting rights29.81 % | FromApr 1, 2025 | |
| Ownership29.81 % | Voting rights29.81 % | FromJan 19, 2024 | |
| Ownership29.81 % | Voting rights29.81 % | FromJan 19, 2024 | |
| Ownership29.81 % | Voting rights29.81 % | FromJan 19, 2024 | |
| Ownership29.81 % | Voting rights29.81 % | FromJan 19, 2024 | |
| Ownership29.81 % | Voting rights29.81 % | FromJan 19, 2024 | |
| Ownership29.81 % | Voting rights29.81 % | FromJan 19, 2024 | |
| Ownership29.81 % | Voting rights29.81 % | FromJan 19, 2024 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| 🇧🇪Bioqube Factory Fund I CommV | Ownership through Direct | 25–33.32 % |
| NOVO NORDISK FONDEN | Ownership through | 25–33.32 % |
| 🇧🇪Korys Investments | Ownership through Direct | 15–19.99 % |
| Dennis Vestergaard Pedersen | Ownership through | 3.75–6.67 % |
| Heidi Gytz Olesen | Ownership through | 3.75–6.67 % |
| Mikael Becher Lykkegaard Winkler | Ownership through | 3.75–6.67 % |
| Nick Stub Laursen | Ownership through | 3.75–6.67 % |